Physician profile
Ranjith Shetty
NPI 1316041270
$49,617.86
in general payments reported to CMS, 2019-2025
24 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $1,612 · 2021: $7,525 · 2022: $1,652 · 2023: $3,911 · 2024: $1,905 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,679 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,679.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $23,126.08 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $11,547.94 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $8,699.76 | 2019-2020 | |
| Abiomed | $1,547.92 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,458.57 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Abbott Laboratories | $1,064.79 | 2019-2025 | Aveir, Mitraclip |
| Heartflow, INC. | $460.67 | 2019-2024 | Ffrct |
| Philips North America LLC | $444.79 | 2019-2025 | Peripheral Vascular Undivided, (Ao0) Igt Devices Intracardiac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $241.94 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $195.28 | 2019-2025 | |
| Atricure, INC. | $136.06 | 2023 | |
| W. L. Gore & Associates, INC. | $118.22 | 2019 | |
| Chiesi USA, INC. | $116.12 | 2023 | Kengreal |
| Inari Medical, INC. | $113.37 | 2020 | |
| Kestra Medical Technology Services, INC. | $102.66 | 2025 | Assure Wcd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $74.47 | 2022 | |
| Cardiva Medical, INC. | $27.50 | 2024 | Cardiva Vascade 6/7f Vcs |
| Cvrx, INC. | $27.14 | 2025 | Barostim Neo System |
| Novo Nordisk INC | $24.87 | 2025 | Wegovy |
| Biosense Webster, INC. | $20.76 | 2023 | Carto 3 |
| Terumo Medical Corporation | $19.25 | 2024 | Glidewire |
| E.R. Squibb & Sons, L.L.C. | $18.09 | 2025 | Camzyos |
| Amgen INC. | $15.81 | 2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $15.80 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjith Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.